CVA Family Office’s Innospec IOSP Stock Holding History
Bought
Maintained
Sold
Other funds holding IOSP
CVA Family Office's IOSP Position: Q2 2026 in Review
CVA Family Office increased its Innospec (IOSP) stake by 25% in Q2 2026, buying an estimated $554 and bringing the position to 35 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1444.
CVA Family Office first reported a position in IOSP in Q1 2025 and has held it in 3 quarters since. 281 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.
- CVA Family Office held 35 shares of Innospec worth $2.85K as of Q2 2026.
- CVA Family Office bought 7 Innospec shares in Q2 2026, an estimated $554.
- Innospec made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1444 holding.
- CVA Family Office first reported a position in Innospec in Q1 2025 and has held it in 3 quarters since.
- 281 funds tracked by Wall St. Rank held Innospec as of Q2 2026.
Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.